Playback speed
10 seconds
ASCO® 2023 Insights: "Results From a Phase 1 Clinical Study of the All-Oral Regimen of CC-486 and Venetoclax for AML"
By
Insights from 2023 ASCO® Annual Meeting
FEATURING
Maria Amaya
By
Insights from 2023 ASCO® Annual Meeting
FEATURING
Maria Amaya
418 views
June 7, 2023
Login to view comments.
Click here to Login